Biological effects of IL-21 on different immune cells and its role in autoimmune diseases

Immunobiology

Volumn 221, Issue 2, 2016, Pages 357-367

  Gharibi, Tohid ^a,b   Majidi, Jafar ^a   Kazemi, Tohid ^a   Dehghanzadeh, Rashedeh ^a   Motallebnezhad, Morteza ^a   Babaloo, Zohreh ^a,b  

^a TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Autoimmune diseases; Cytokines; Interleukin 21

Indexed keywords

CD16 ANTIGEN; CD40 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 21; INTERLEUKIN 23 RECEPTOR; INTERLEUKIN 6; INTERLEUKIN 8; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR; MACROPHAGE INFLAMMATORY PROTEIN 3ALPHA; MATRIX METALLOPROTEINASE; TRANSFORMING GROWTH FACTOR BETA; IMMUNOLOGIC FACTOR; INTERLEUKIN DERIVATIVE;

ANTIGEN PRESENTATION; APOPTOSIS; AUTOCRINE EFFECT; AUTOIMMUNE DISEASE; B LYMPHOCYTE; BIOLOGICAL ACTIVITY; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL DIFFERENTIATION; CELL FUNCTION; CELL PROLIFERATION; CELL VIABILITY; CYTOKINE PRODUCTION; CYTOTOXICITY; DENDRITIC CELL; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; HUMAN; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; INFLAMMATORY BOWEL DISEASE; INSULIN DEPENDENT DIABETES MELLITUS; MACROPHAGE; MULTIPLE SCLEROSIS; NATURAL KILLER CELL; NATURAL KILLER T CELL; NONHUMAN; OSTEOCLASTOGENESIS; PROTEIN EXPRESSION; PSORIASIS; REVIEW; RHEUMATOID ARTHRITIS; SIGNAL TRANSDUCTION; SYSTEMIC LUPUS ERYTHEMATOSUS; TH17 CELL; ANIMAL; ANTAGONISTS AND INHIBITORS; CLINICAL TRIAL (TOPIC); DISEASE MODEL; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; HELPER CELL; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; PATHOLOGY; PLASMA CELL; REGULATORY T LYMPHOCYTE;

ANIMALS; AUTOIMMUNE DISEASES; B-LYMPHOCYTE SUBSETS; CELL DIFFERENTIATION; CLINICAL TRIALS AS TOPIC; DENDRITIC CELLS; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION; HUMANS; IMMUNOLOGIC FACTORS; INTERLEUKINS; KILLER CELLS, NATURAL; LYMPHOCYTE ACTIVATION; PLASMA CELLS; T-LYMPHOCYTES, HELPER-INDUCER; T-LYMPHOCYTES, REGULATORY;

EID: 84989788808     PISSN: 01712985     EISSN: 18783279     Source Type: Journal    
DOI: 10.1016/j.imbio.2015.09.021     Document Type: Review

References (155)

1. Allard, E.L., Hardy, M.P., Leignadier, J., Marquis, M., Rooney, J., Lehoux, D., et al. Overexpression of IL21 promotes massive CD8+ memory T cell accumulation. Eur. J. Immunol. 37:11 (2007), 3069–3077.
2. Alves, N.L., Arosa, F.A., van Lier, R.A., IL-21 sustains CD28 expression on IL-15-activated human naive CD8+ T cells. J. Immunol. 175:2 (2005), 755–762.
3. Andersson, A., Feldmann, M., Brennan, F., Neutralizing IL-21 and IL-15 inhibits pro-inflammatory cytokine production in rheumatoid arthritis. Scand. J. Immunol. 68:1 (2008), 103–111.
4. Arnett, F.C., Edworthy, S.M., Bloch, D.A., McShane, D.J., Fries, J.F., Cooper, N.S., et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 31:3 (1988), 315–324.
5. Asano, K., Ikegami, H., Fujisawa, T., Nishino, M., Nojima, K., Kawabata, Y., et al. Molecular scanning of interleukin-21 gene and genetic susceptibility to type 1 diabetes. Hum. Immunol. 68:5 (2007), 384–391.
6. Asao, H., Okuyama, C., Kumaki, S., Ishii, N., Tsuchiya, S., Foster, D., et al. Cutting edge: the common γ-chain is an indispensable subunit of the IL-21 receptor complex. J. Immunol. 167:1 (2001), 1–5.
7. Attridge, K., Wang, C.J., Wardzinski, L., Kenefeck, R., Chamberlain, J.L., Manzotti, C., et al. IL-21 inhibits T cell IL-2 production and impairs Treg homeostasis. Blood 119:20 (2012), 4656–4664.
8. Attridge, K., Kenefeck, R., Wardzinski, L., Qureshi, O.S., Wang, C.J., Manzotti, C., et al. IL-21 promotes CD4 T cell responses by phosphatidylinositol 3-kinase-dependent upregulation of CD86 on B cells. J. Immunol. 192:5 (2014), 2195–2201.
9. Avery, D.T., Bryant, V.L., Ma, C.S., de Waal Malefyt, R., Tangye, S.G., IL-21-induced isotype switching to IgG and IgA by human naive B cells is differentially regulated by IL-4. J. Immunol. 181:3 (2008), 1767–1779.
10. Avery, D.T., Deenick, E.K., Ma, C.S., Suryani, S., Simpson, N., Chew, G.Y., et al. B cell–intrinsic signaling through IL-21 receptor and STAT3 is required for establishing long-lived antibody responses in humans. J. Exp. Med. 207:1 (2010), 155–171.
11. Barker, B.R., Gladstone, M.N., Gillard, G.O., Panas, M.W., Letvin, N.L., Critical role for IL-21 in both primary and memory anti-viral CD8+ T-cell responses. Eur. J. Immunol. 40:11 (2010), 3085–3096.
12. Bettelli, E., Korn, T., Oukka, M., Kuchroo, V.K., Induction and effector functions of TH17 cells. Nature 453:7198 (2008), 1051–1057.
13. Bos, J.D., De Rie, M.A., The pathogenesis of psoriasis: immunological facts and speculations. Immunol. Today 20:1 (1999), 40–46.
14. Brady, J., Hayakawa, Y., Smyth, M.J., Nutt, S.L., IL-21 induces the functional maturation of murine NK cells. J. Immunol. 172:4 (2004), 2048–2058.
15. Brandt, K., Bulfone-Paus, S., Jenckel, A., Foster, D.C., Paus, R., Rückert, R., Interleukin-21 inhibits dendritic cell-mediated T cell activation and induction of contact hypersensitivity in vivo. J. Invest. Dermatol. 121:6 (2003), 1379–1382.
16. Brandt, K., Bulfone-Paus, S., Foster, D.C., Rückert, R., Interleukin-21 inhibits dendritic cell activation and maturation. Blood 102:12 (2003), 4090–4098.
17. Bubier, J., Bennett, S., Sproule, T., Lyons, B., Olland, S., Young, D., et al. Treatment of BXSB-Yaa mice with IL-21R-Fc fusion protein minimally attenuates systemic lupus erythematosus. Ann. N.Y. Acad. Sci. 1110:1 (2007), 590–601.
18. Bubier, J.A., Sproule, T.J., Foreman, O., Spolski, R., Shaffer, D.J., Morse, H.C., et al. A critical role for IL-21 receptor signaling in the pathogenesis of systemic lupus erythematosus in BXSB-Yaa mice. Proc. Natl. Acad. Sci. 106:5 (2009), 1518–1523.
19. Burgess, S.J., Marusina, A.I., Pathmanathan, I., Borrego, F., Coligan, J.E., IL-21 down-regulates NKG2D/DAP10 expression on human NK and CD8+ T cells. J. Immunol. 176:3 (2006), 1490–1497.
20. Calame, K.L., Lin, K.-I., Tunyaplin, C., Regulatory mechanisms that determine the development and function of plasma cells. Annu. Rev. Immunol. 21:1 (2003), 205–230.
21. Cao, A., Yao, S., Gong, B., Nurieva, R., Elson, C., Cong, Y., Interleukin (IL)-21 promotes intestinal IgA response to microbiota. Mucosal Immunol. 8:5 (2015), 1072–1082.
22. Caprioli, F., Sarra, M., Caruso, R., Stolfi, C., Fina, D., Sica, G., et al. Autocrine regulation of IL-21 production in human T lymphocytes. J. Immunol. 180:3 (2008), 1800–1807.
23. Carbone, G., Wilson, A., Diehl, S.A., Bunn, J., Cooper, S.M., Rincon, M., Interleukin-6 receptor blockade selectively reduces IL-21 production by CD4 T cells and IgG4 autoantibodies in rheumatoid arthritis. Int. J. Biol. Sci., 9(3), 2013, 279.
24. Caruso, R., Fina, D., Peluso, I., Fantini, M.C., Tosti, C., Blanco, G.D.V., et al. IL-21 is highly produced in Helicobacter pylori-infected gastric mucosa and promotes gelatinases synthesis. J. Immunol. 178:9 (2007), 5957–5965.
25. Caruso, R., Fina, D., Peluso, I., Stolfi, C., Fantini, M.C., Gioia, V., et al. A functional role for interleukin-21 in promoting the synthesis of the T-cell chemoattractant, MIP-3α, by gut epithelial cells. Gastroenterology 132:1 (2007), 166–175.
26. Caruso, R., Botti, E., Sarra, M., Esposito, M., Stolfi, C., Diluvio, L., et al. Involvement of interleukin-21 in the epidermal hyperplasia of psoriasis. Nat. Med. 15:9 (2009), 1013–1015.
27. Casey, K.A., Mescher, M.F., IL-21 promotes differentiation of naive CD8 T cells to a unique effector phenotype. J. Immunol. 178:12 (2007), 7640–7648.
28. Caven, T.H., Shelburne, A., Sato, J., Yee, C.-L., Becker, S., Conrad, D.H., IL-21 dependent IgE production in human and mouse in vitro culture systems is cell density and cell division dependent and is augmented by IL-10. Cell. Immunol. 238:2 (2005), 123–134.
29. Christensen, J.R., Börnsen, L., Ratzer, R., Piehl, F., Khademi, M., Olsson, T., et al. Systemic inflammation in progressive multiple sclerosis involves follicular T-helper, Th17-and activated B-cells and correlates with progression. PLoS One, 8(3), 2013, e57820.
30. Coquet, J.M., Kyparissoudis, K., Pellicci, D.G., Besra, G., Berzins, S.P., Smyth, M.J., et al. IL-21 is produced by NKT cells and modulates NKT cell activation and cytokine production. J. Immunol. 178:5 (2007), 2827–2834.
31. Coquet, J.M., Chakravarti, S., Smyth, M.J., Godfrey, D.I., Cutting edge: IL-21 is not essential for Th17 differentiation or experimental autoimmune encephalomyelitis. J. Immunol. 180:11 (2008), 7097–7101.
32. Cristina, L.M., Vieira, P., Aarrass, S., Newsom-Davis, T., Tak, P., Screaton, G., A8:9 rheumatoid arthritis synovial IL-21+ CD4+ T cells specifically induce matrix metalloproteinase production by fibroblast-like synoviocytes. Ann. Rheum. Dis. 73 (2014), A79–A.
33. Crotty, S., A brief history of T cell help to B cells. Nat. Rev. Immunol. 15:3 (2015), 185–189.
34. Datta, S., Sarvetnick, N.E., IL-21 limits peripheral lymphocyte numbers through T cell homeostatic mechanisms. PLoS One, 3(9), 2008, e3118.
35. de Armas, L., Liu, H., Strbo, N., IL-21 augments natural killer effector functions in chronically HIV-infected individuals. AIDS 22:August (13) (2008), 1551–1560.
36. De Nitto, N., Sarra, M., Pallone, F., Monteleone, G., Interleukin-21 triggers effector cell responses in the gut. World J. Gastroenterol., 16(29), 2010, 3638.
37. Denny, P., Lord, C.J., Hill, N.J., Goy, J.V., Levy, E.R., Podolin, P.L., et al. Mapping of the IDDM locus Idd3 to a 0.35-cM interval containing the interleukin-2 gene. Diabetes 46:4 (1997), 695–700.
38. Diehl, S.A., Schmidlin, H., Nagasawa, M., van Haren, S.D., Kwakkenbos, M.J., Yasuda, E., et al. STAT3-mediated up-regulation of BLIMP1 Is coordinated with BCL6 down-regulation to control human plasma cell differentiation. J. Immunol. 180:7 (2008), 4805–4815.
39. Dienz, O., Eaton, S.M., Bond, J.P., Neveu, W., Moquin, D., Noubade, R., et al. The induction of antibody production by IL-6 is indirectly mediated by IL-21 produced by CD4+ T cells. J. Exp. Med. 206:1 (2009), 69–78.
40. Distler, J.H., Jüngel, A., Kowal-Bielecka, O., Michel, B.A., Gay, R.E., Sprott, H., et al. Expression of interleukin-21 receptor in epidermis from patients with systemic sclerosis. Arthritis Rheum. 52:3 (2005), 856–864.
41. Dullaers, M., Li, D., Xue, Y., Ni, L., Gayet, I., Morita, R., et al. AT cell-dependent mechanism for the induction of human mucosal homing immunoglobulin A-secreting plasmablasts. Immunity 30:1 (2009), 120–129.
42. Endo, K., Shiga, H., Kinouchi, Y., Shimosegawa, T., Inflammatory bowel disease: IBD. Rinsho byori (Japanese) 57:6 (2009), 527–532.
43. Erman, B., Bilic, I., Hirschmugl, T., Salzer, E., Çağdaş, D.A., Esenboga, S., et al. Combined immunodeficiency with CD4 lymphopenia and sclerosing cholangitis caused by a novel loss-of-function mutation affecting IL21R. Haematologica 100:6 (2015), e216–e219.
44. Ettinger, R., Sims, G.P., Fairhurst, A.-M., Robbins, R., da Silva, Y.S., Spolski, R., et al. IL-21 induces differentiation of human naive and memory B cells into antibody-secreting plasma cells. J. Immunol. 175:12 (2005), 7867–7879.
45. Feng, P.H., Systemic lupus erythematosus. Ann. N.Y. Acad. Sci. 1108:1 (2007), 114–120.
46. Ferrari-Lacraz, S., Chicheportiche, R., Schneiter, G., Molnarfi, N., Villard, J., Dayer, J.-M., IL-21 promotes survival and maintains a naive phenotype in human CD4+ T lymphocytes. Int. Immunol. 20:8 (2008), 1009–1018.
47. Ferreira, R.C., Simons, H.Z., Thompson, W.S., Cutler, A.J., Dopico, X.C., Smyth, D.J., et al. IL-21 production by CD4+ effector T cells and frequency of circulating follicular helper T cells are increased in type 1 diabetes patients. Diabetologia 58:4 (2015), 781–790.
48. Fina, D., Sarra, M., Fantini, M.C., Rizzo, A., Caruso, R., Caprioli, F., et al. Regulation of gut inflammation and th17 cell response by interleukin-21. Gastroenterology 134:4 (2008), 1038–1048 e2.
49. Fröhlich, A., Kisielow, J., Schmitz, I., Freigang, S., Shamshiev, A.T., Weber, J., et al. IL-21R on T cells is critical for sustained functionality and control of chronic viral infection. Science 324:5934 (2009), 1576–1580.
50. Frederiksen, K.S., Lundsgaard, D., Freeman, J.A., Hughes, S.D., Holm, T.L., Skrumsager, B.K., et al. IL-21 induces in vivo immune activation of NK cells and CD8+ T cells in patients with metastatic melanoma and renal cell carcinoma. Cancer Immunol. Immunother. 57:10 (2008), 1439–1449.
51. Gharibi, T., Ahmadi, M., Seyfizadeh, N., Jadidi-Niaragh, F., Yousefi, M., Immunomodulatory characteristics of mesenchymal stem cells and their role in the treatment of multiple sclerosis. Cell. Immunol. 293:Feburary (2) (2015), 113–121.
52. Gharibi, T., Kazemi, T., Aliparasti, M.R., Farhoudi, M., Almasi, S., Dehghanzadeh, R., Investigation of IL-21 gene polymorphisms (rs2221903, rs2055979) in cases with multiple sclerosis of Azerbaijan, Northwest Iran. Am. J. Clin. Exp. Immunol., 4(1), 2015, 7.
53. Godfrey, D.I., Kronenberg, M., Going both ways: immune regulation via CD1d-dependent NKT cells. J. Clin. Invest., 114(10), 2004, 1379.
54. Good, K.L., Bryant, V.L., Tangye, S.G., Kinetics of human B cell behavior and amplification of proliferative responses following stimulation with IL-21. J. Immunol. 177:8 (2006), 5236–5247.
55. Guan, L.-J., Wang, X., Meng, S., Shi, L.-F., Jiang, W.-J., Xiao, L., et al. Increased IL-21/IL-21R expression and its proinflammatory effects in autoimmune thyroid disease. Cytokine 72:2 (2015), 160–165.
56. Hagn, M., Belz, G.T., Kallies, A., Sutton, V.R., Thia, K.Y., Tarlinton, D.M., et al. Activated mouse B cells lack expression of granzyme B. J. Immunol. 188:8 (2012), 3886–3892.
57. Hagn, M., Sontheimer, K., Dahlke, K., Brueggemann, S., Kaltenmeier, C., Beyer, T., Human B cells differentiate into granzyme B-secreting cytotoxic B lymphocytes upon incomplete T-cell help. Immunol. Cell Biol. 90:4 (2012), 457–467.
58. Herber, D., Brown, T.P., Liang, S., Young, D.A., Collins, M., Dunussi-Joannopoulos, K., IL-21 has a pathogenic role in a lupus-prone mouse model and its blockade with IL-21R:Fc reduces disease progression. J. Immunol. 178:6 (2007), 3822–3830.
59. Hinrichs, C.S., Spolski, R., Paulos, C.M., Gattinoni, L., Kerstann, K.W., Palmer, D.C., et al. IL-2 and IL-21 confer opposing differentiation programs to CD8+ T cells for adoptive immunotherapy. Blood 111:11 (2008), 5326–5333.
60. Iannello, A., Tremblay, C., Routy, J.-P., Boulassel, M.-R., Toma, E., Ahmad, A., Decreased levels of circulating IL-21 in HIV-infected AIDS patients: correlation with CD4+ T-cell counts. Viral Immunol. 21:3 (2008), 385–388.
61. Iannello, A., Boulassel, M.-R., Samarani, S., Tremblay, C., Toma, E., Routy, J.-P., et al. IL-21 enhances NK cell functions and survival in healthy and HIV-infected patients with minimal stimulation of viral replication. J. Leukoc. Biol. 87:5 (2010), 857–867.
62. Ivanov, I.I., de Llanos Frutos, R., Manel, N., Yoshinaga, K., Rifkin, D.B., Sartor, R.B., et al. Specific microbiota direct the differentiation of IL-17-producing T-helper cells in the mucosa of the small intestine. Cell Host Microbe 4:4 (2008), 337–349.
63. Ives, M.L., Ma, C.S., Palendira, U., Chan, A., Bustamante, J., Boisson-Dupuis, S., et al. Signal transducer and activator of transcription 3 (STAT3) mutations underlying autosomal dominant hyper-IgE syndrome impair human CD8+ T-cell memory formation and function. J. Allergy Clin. Immunol. 132:2 (2013), 400–411 e9.
64. Izui, S., Ibnou-Zekri, N., Fossati-Jimack, L., Iwamoto, M., Lessons from BXSB and related mouse models. Int. Rev. Immunol. 19:4-5 (2000), 447–472.
65. Jüngel, A., Distler, J.H., Kurowska‐Stolarska, M., Seemayer, C.A., Seibl, R., Forster, A., et al. Expression of interleukin-21 receptor, but not interleukin-21, in synovial fibroblasts and synovial macrophages of patients with rheumatoid arthritis. Arthritis Rheum. 50:5 (2004), 1468–1476.
66. Jang, E., Cho, S.-H., Park, H., Paik, D.-J., Kim, J.M., Youn, J., A positive feedback loop of IL-21 signaling provoked by homeostatic CD4+ CD25− T cell expansion is essential for the development of arthritis in autoimmune K/BxN mice. J. Immunol. 182:8 (2009), 4649–4656.
67. Janssen, E.M., Droin, N.M., Lemmens, E.E., Pinkoski, M.J., Bensinger, S.J., Ehst, B.D., et al. CD4+ T-cell help controls CD8+ T-cell memory via TRAIL-mediated activation-induced cell death. Nature 434:7029 (2005), 88–93.
68. Jin, H., Carrio, R., Yu, A., Malek, T.R., Distinct activation signals determine whether IL-21 induces B cell costimulation, growth arrest, or Bim-dependent apoptosis. J. Immunol. 173:1 (2004), 657–665.
69. John, S.Y., Du, M., Zajac, A.J., A vital role for interleukin-21 in the control of a chronic viral infection. Science 324:5934 (2009), 1572–1576.
70. John, S.Y., Ingram, J.T., Zajac, A.J., IL-21 deficiency influences CD8 T cell quality and recall responses following an acute viral infection. J. Immunol. 185:8 (2010), 4835–4845.
71. Johnston, R.J., Poholek, A.C., DiToro, D., Yusuf, I., Eto, D., Barnett, B., et al. Bcl6 and Blimp-1 are reciprocal and antagonistic regulators of T follicular helper cell differentiation. Science 325:5943 (2009), 1006–1010.
72. Kaka, A.S., Shaffer, D.R., Hartmeier, R., Leen, A.M., Lu, A., Bear, A., et al. Genetic modification of T cells with IL-21 enhances antigen presentation and generation of central memory tumor-specific cytotoxic T lymphocytes. J. Immunother. (Hagerstown Md: 1997), 32(7), 2009, 726.
73. Kaltenmeier, C., Gawanbacht, A., Beyer, T., Lindner, S., Trzaska, T., van der Merwe, J.A., et al. CD4+ T cell-derived IL-21 and deprivation of CD40 signaling favor the in vivo development of Granzyme B—expressing regulatory B Cells in HIV patients. J. Immunol. 194:8 (2015), 3768–3777.
74. Kasaian, M.T., Whitters, M.J., Carter, L.L., Lowe, L.D., Jussif, J.M., Deng, B., et al. IL-21 limits NK cell responses and promotes antigen-specific T cell activation: a mediator of the transition from innate to adaptive immunity. Immunity 16:4 (2002), 559–569.
75. King, C., Ilic, A., Koelsch, K., Sarvetnick, N., Homeostatic expansion of T cells during immune insufficiency generates autoimmunity. Cell 117:2 (2004), 265–277.
76. King, C., Tangye, S.G., Mackay, C.R., T follicular helper (TFH) cells in normal and dysregulated immune responses. Annu. Rev. Immunol. 26 (2008), 741–766.
77. Korn, T., Bettelli, E., Gao, W., Awasthi, A., Jäger, A., Strom, T.B., et al. IL-21 initiates an alternative pathway to induce proinflammatory TH17 cells. Nature 448:7152 (2007), 484–487.
78. Korn, T., Bettelli, E., Oukka, M., Kuchroo, V.K., IL-17 and Th17 cells. Annu. Rev. Immunol. 27 (2009), 485–517.
79. Kotlarz, D., Zietara, N., Uzel, G., Weidemann, T., Braun, C.J., Diestelhorst, J., et al. Loss-of-function mutations in the IL-21 receptor gene cause a primary immunodeficiency syndrome. J. Exp. Med. 210:March (3) (2013), 433–443 11.
80. Kwok, S.K., Cho, M.L., Park, M.K., Oh, H.J., Park, J.S., Her, Y.M., et al. Interleukin-21 promotes osteoclastogenesis in humans with rheumatoid arthritis and in mice with collagen-induced arthritis. Arthritis Rheum. 64:3 (2012), 740–751.
81. Kwon, H., Thierry-Mieg, D., Thierry-Mieg, J., Kim, H.-P., Oh, J., Tunyaplin, C., et al. Analysis of interleukin-21-induced Prdm1 gene regulation reveals functional cooperation of STAT3 and IRF4 transcription factors. Immunity 31:6 (2009), 941–952.
82. Lüthje, K., Kallies, A., Shimohakamada, Y., Belz, G.T., Light, A., Tarlinton, D.M., et al. The development and fate of follicular helper T cells defined by an IL-21 reporter mouse. Nat. Immunol. 13:5 (2012), 491–498.
83. Li, Y., Yee, C., IL-21-mediated Foxp3 suppression leads to enhanced generation of antigen-specific CD8+ cytotoxic T lymphocytes. Blood 111:1 (2008), 229–235.
84. Li, Y., Bleakley, M., Yee, C., IL-21 influences the frequency, phenotype, and affinity of the antigen-specific CD8 T cell response. J. Immunol. 175:4 (2005), 2261–2269.
85. Li, J., Shen, W., Kong, K., Liu, Z., Interleukin-21 induces T-cell activation and proinflammatory cytokine secretion in rheumatoid arthritis. Scand. J. Immunol. 64:5 (2006), 515–522.
86. Liu, Y., Helms, C., Liao, W., Zaba, L.C., Duan, S., Gardner, J., et al. A genome-wide association study of psoriasis and psoriatic arthritis identifies new disease loci. PLoS Genet., 4(4), 2008, e1000041.
87. Li, Q., Ye, L.-J., Ren, H.-L., Huyan, T., Li, J., Shi, J.-L., et al. Multiple effects of IL-21 on human NK cells in ex vivo expansion. Immunobiology 220:July (7) (2015), 876–888.
88. Linterman, M.A., Beaton, L., Yu, D., Ramiscal, R.R., Srivastava, M., Hogan, J.J., et al. IL-21 acts directly on B cells to regulate Bcl-6 expression and germinal center responses. J. Exp. Med. 207:2 (2010), 353–363.
89. Liu, S.M., Lee, D.H., Sullivan, J.M., Chung, D., Jäger, A., Shum, B.O., et al. Differential IL-21 signaling in APCs leads to disparate Th17 differentiation in diabetes-susceptible NOD and diabetes-resistant NOD Idd3 mice. J. Clin. Invest., 121(11), 2011, 4303.
90. Márquez, A., Orozco, G., Martínez, A., Palomino-Morales, R., Fernández-Arquero, M., Mendoza, J.L., et al. Novel association of the interleukin 2–interleukin 21 region with inflammatory bowel disease. Am. J. Gastroenterol. 104:8 (2009), 1968–1975.
91. Ma, J., Zhu, C., Ma, B., Tian, J., Baidoo, S.E., Mao, C., et al. Increased frequency of circulating follicular helper T cells in patients with rheumatoid arthritis. Clin. Dev. Immunol., 2012, 2012.
92. Maeda, M., Yanagawa, Y., Iwabuchi, K., Minami, K., Nakamaru, Y., Takagi, D., et al. IL-21 enhances dendritic cell ability to induce interferon-γ production by natural killer T cells. Immunobiology 212:7 (2007), 537–547.
93. Mattner, J., DeBord, K.L., Ismail, N., Goff, R.D., Cantu, C., Zhou, D., et al. Exogenous and endogenous glycolipid antigens activate NKT cells during microbial infections. Nature 434:7032 (2005), 525–529.
94. McGuire, H.M., Vogelzang, A., Hill, N., Flodström-Tullberg, M., Sprent, J., King, C., Loss of parity between IL-2 and IL-21 in the NOD Idd3 locus. Proc. Natl. Acad. Sci. 106:46 (2009), 19438–19443.
95. McGuire, H.M., Walters, S., Vogelzang, A., Lee, C.M., Webster, K.E., Sprent, J., et al. Interleukin-21 is critically required in autoimmune and allogeneic responses to islet tissue in murine models. Diabetes 60:3 (2011), 867–875.
96. McInnes, I.B., Schett, G., The pathogenesis of rheumatoid arthritis. N. Engl. J. Med. 365:23 (2011), 2205–2219.
97. McPhee, C.G., Bubier, J.A., Sproule, T.J., Park, G., Steinbuck, M.P., Schott, W.H., et al. IL-21 is a double-edged sword in the systemic lupus erythematosus-like disease of BXSB Yaa mice. J. Immunol. 191:9 (2013), 4581–4588.
98. Mehta, D.S., Wurster, A.L., Whitters, M.J., Young, D.A., Collins, M., Grusby, M.J., IL-21 induces the apoptosis of resting and activated primary B cells. J. Immunol. 170:8 (2003), 4111–4118.
99. Miossec, P., Kolls, J.K., Targeting IL-17 and TH17 cells in chronic inflammation. Nat. Rev. Drug Discov. 11:10 (2012), 763–776.
100. Mitoma, H., Horiuchi, T., Kimoto, Y., Tsukamoto, H., Uchino, A., Tamimoto, Y., et al. Decreased expression of interleukin-21 receptor on peripheral B lymphocytes in systemic lupus erythematosus. Int. J. Mol. Med. 16:4 (2005), 609–615.
101. Monteleone, G., Monteleone, I., Fina, D., Vavassori, P., Blanco, G.D.V., Caruso, R., et al. Interleukin-21 enhances T-helper cell type I signaling and interferon-γ production in Crohn's disease. Gastroenterology 128:3 (2005), 687–694.
102. Monteleone, G., Caruso, R., Fina, D., Peluso, I., Gioia, V., Stolfi, C., et al. Control of matrix metalloproteinase production in human intestinal fibroblasts by interleukin 21. Gut 55:12 (2006), 1774–1780.
103. Niu, X., He, D., Zhang, X., Yue, T., Li, N., Zhang, J.Z., et al. IL-21 regulates Th17 cells in rheumatoid arthritis. Hum. Immunol. 71:4 (2010), 334–341.
104. Noguchi, M., Yi, H., Rosenblatt, H.M., Filipovich, A.H., Adelstein, S., Modi, W.S., et al. Interleukin-2 receptor γ chain mutation results in X-linked severe combined immunodeficiency in humans. Cell 73:1 (1993), 147–157.
105. Nohra, R., Beyeen, A., Guo, J., Khademi, M., Sundqvist, E., Hedreul, M., et al. RGMA and IL21R show association with experimental inflammation and multiple sclerosis. Genes Immun. 11:4 (2010), 279–293.
106. Nurieva, R., Yang, X.O., Martinez, G., Zhang, Y., Panopoulos, A.D., Ma, L., et al. Essential autocrine regulation by IL-21 in the generation of inflammatory T cells. Nature 448:7152 (2007), 480–483.
107. Nurieva, R.I., Chung, Y., Martinez, G.J., Yang, X.O., Tanaka, S., Matskevitch, T.D., et al. Bcl6 mediates the development of T follicular helper cells. Science 325:5943 (2009), 1001–1005.
108. Ohteki, T., Suzue, K., Maki, C., Ota, T., Koyasu, S., Critical role of IL-15–IL-15R for antigen-presenting cell functions in the innate immune response. Nat. Immunol. 2:12 (2001), 1138–1143.
109. Ortega, C., Fernández, A.S., Carrillo, J.M., Romero, P., Molina, I.J., Moreno, J.C., et al. IL-17-producing CD8+ T lymphocytes from psoriasis skin plaques are cytotoxic effector cells that secrete Th17-related cytokines. J. Leukoc. Biol. 86:2 (2009), 435–443.
110. Ozaki, K., Kikly, K., Michalovich, D., Young, P.R., Leonard, W.J., Cloning of a type I cytokine receptor most related to the IL-2 receptor β chain. Proc. Natl. Acad. Sci. 97:21 (2000), 11439–11444.
111. Ozaki, K., Spolski, R., Feng, C.G., Qi, C.-F., Cheng, J., Sher, A., et al. A critical role for IL-21 in regulating immunoglobulin production. Science 298:5598 (2002), 1630–1634.
112. Ozaki, K., Spolski, R., Ettinger, R., Kim, H.-P., Wang, G., Qi, C.-F., et al. Regulation of B cell differentiation and plasma cell generation by IL-21, a novel inducer of Blimp-1 and Bcl-6. J. Immunol. 173:9 (2004), 5361–5371.
113. Pérez-Mazliah, D., Ng, D., Freitas do Rosario, A.P., McLaughlin, S., Mastelic-Gavillet, B., Sodenkamp, J., et al. Disruption of IL-21 signaling affects T Cell-B cell interactions and abrogates protective humoral immunity to malaria. PLoS Pathog., 11(3), 2015, e1004715.
114. Parrish-Novak, J., Dillon, S.R., Nelson, A., Hammond, A., Sprecher, C., Gross, J.A., et al. Interleukin 21 and its receptor are involved in NK cell expansion and regulation of lymphocyte function. Nature 408:6808 (2000), 57–63.
115. Pelletier, M., Bouchard, A., Girard, D., In vivo and in vitro roles of IL-21 in inflammation. J. Immunol. 173:12 (2004), 7521–7530.
116. Peluso, I., Fantini, M.C., Fina, D., Caruso, R., Boirivant, M., MacDonald, T.T., et al. IL-21 counteracts the regulatory T cell-mediated suppression of human CD4+ T lymphocytes. J. Immunol. 178:2 (2007), 732–739.
117. Piao, W.H., Jee, Y., Liu, R., Coons, S., Kala, M., Collins, M., et al. IL‐21 Modulates CD4+ CD25+ regulatory T‐Cell homeostasis in experimental autoimmune encephalomyelitis. Scand. J. Immunol 67:1 (2008), 37–46.
118. Pot, C., Jin, H., Awasthi, A., Liu, S.M., Lai, C.-Y., Madan, R., et al. Cutting edge: IL-27 induces the transcription factor c-Maf, cytokine IL-21, and the costimulatory receptor ICOS that coordinately act together to promote differentiation of IL-10-producing Tr1 cells. J. Immunol. 183:2 (2009), 797–801.
119. Puga, I., Cols, M., Barra, C.M., He, B., Cassis, L., Gentile, M., et al. B cell-helper neutrophils stimulate the diversification and production of immunoglobulin in the marginal zone of the spleen. Nat. Immunol. 13:February (2) (2012), 170–180.
120. Rückert, R., Bulfone-Paus, S., Brandt, K., Interleukin-21 stimulates antigen uptake, protease activity, survival and induction of CD4+ T cell proliferation by murine macrophages. Clin. Exp. Immunol. 151:3 (2008), 487–495.
121. Rasmussen, T.K., Andersen, T., Hvid, M., Hetland, M.L., Hørslev-Petersen, K., Stengaard-Pedersen, K., et al. Increased interleukin 21 (IL-21) and IL-23 are associated with increased disease activity and with radiographic status in patients with early rheumatoid arthritis. J. Rheumatol. 37:10 (2010), 2014–2020.
122. Søndergaard, H., Skak, K., IL-21: roles in immunopathology and cancer therapy. Tissue Antigens 74:6 (2009), 467–479.
123. Sarra, M., Monteleone, I., Stolfi, C., Fantini, M.C., Sileri, P., Sica, G., et al. Interferon-gamma-expressing cells are a major source of interleukin-21 in inflammatory bowel diseases. Inflamm. Bowel Dis. 16:8 (2010), 1332–1339.
124. Sawalha, A.H., Kaufman, K.M., Kelly, J.A., Adler, A.J., Aberle, T., Kilpatrick, J., et al. Genetic association of interleukin-21 polymorphisms with systemic lupus erythematosus. Ann. Rheum. Dis. 67:4 (2008), 458–461.
125. Schmitz, I., Schneider, C., Fröhlich, A., Frebel, H., Christ, D., Leonard, W.J., et al. IL-21 restricts virus-driven Treg cell expansion in chronic LCMV infection. PLoS Pathog., 9(5), 2013, e1003362.
126. Sengupta, N., MacDonald, T., The role of matrix metalloproteinases in stromal/epithelial interactions in the gut. Physiology 22:6 (2007), 401–409.
127. Shin, H., Wherry, E.J., CD8 T cell dysfunction during chronic viral infection. Curr. Opin. Immunol. 19:4 (2007), 408–415.
128. Sivori, S., Cantoni, C., Parolini, S., Marcenaro, E., Conte, R., Moretta, L., et al. IL-21 induces both rapid maturation of human CD34+ cell precursors towards NK cells and acquisition of surface killer Ig-like receptors. Eur. J. Immunol. 33:12 (2003), 3439–3447.
129. Smyth, M.J., Wallace, M.E., Nutt, S.L., Yagita, H., Godfrey, D.I., Hayakawa, Y., Sequential activation of NKT cells and NK cells provides effective innate immunotherapy of cancer. J. Exp. Med. 201:12 (2005), 1973–1985.
130. Sonderegger, I., Kisielow, J., Meier, R., King, C., Kopf, M., IL-21 and IL-21R are not required for development of Th17 cells and autoimmunity in vivo. Eur. J. Immunol. 38:7 (2008), 1833–1838.
131. Spolski, R., Leonard, W.J., Interleukin-21: basic biology and implications for cancer and autoimmunity. Annu. Rev. Immunol. 26 (2008), 57–79.
132. Spolski, R., Leonard, W.J., Interleukin-21: a double-edged sword with therapeutic potential. Nat. Rev. Drug Discov. 13:5 (2014), 379–395.
133. Spolski, R., Kashyap, M., Robinson, C., Yu, Z., Leonard, W.J., IL-21 signaling is critical for the development of type I diabetes in the NOD mouse. Proc. Natl. Acad. Sci. 105:37 (2008), 14028–14033.
134. Spolski, R., Kim, H.-P., Zhu, W., Levy, D.E., Leonard, W.J., IL-21 mediates suppressive effects via its induction of IL-10. J. Immunol. 182:5 (2009), 2859–2867.
135. Strengell, M., Matikainen, S., Sirén, J., Lehtonen, A., Foster, D., Julkunen, I., et al. IL-21 in synergy with IL-15 or IL-18 enhances IFN-γ production in human NK and T cells. J. Immunol. 170:11 (2003), 5464–5469.
136. Strengell, M., Lehtonen, A., Matikainen, S., Julkunen, I., IL-21 enhances SOCS gene expression and inhibits LPS-induced cytokine production in human monocyte-derived dendritic cells. J. Leukoc. Biol. 79:6 (2006), 1279–1285.
137. Sutherland, A.P., Van Belle, T., Wurster, A.L., Suto, A., Michaud, M., Zhang, D., et al. Interleukin-21 is required for the development of type 1 diabetes in NOD mice. Diabetes 58:5 (2009), 1144–1155.
138. Sutherland, A.P., Joller, N., Michaud, M., Liu, S.M., Kuchroo, V.K., Grusby, M.J., IL-21 promotes CD8+ CTL activity via the transcription factor T-bet. J. Immunol. 190:8 (2013), 3977–3984.
139. Tangye, S.G., Ma, C.S., Brink, R., Deenick, E.K., The good, the bad and the ugly—TFH cells in human health and disease. Nat. Rev. Immunol. 13:6 (2013), 412–426.
140. Tangye, S.G., Advances in IL-21 biology—enhancing our understanding of human disease. Curr. Opin. Immunol. 34 (2015), 107–115.
141. Tedder, T.F., Leonard, W.J., Autoimmunity regulatory B cells—IL-35 and IL-21 regulate the regulators. Nat. Rev. Rheumatol. 10:8 (2014), 452–453.
142. Tzartos, J.S., Craner, M.J., Friese, M.A., Jakobsen, K.B., Newcombe, J., Esiri, M.M., et al. IL-21 and IL-21 receptor expression in lymphocytes and neurons in multiple sclerosis brain. Am. J. Pathol. 178:2 (2011), 794–802.
143. Vinuesa, C.G., Cook, M.C., Angelucci, C., Athanasopoulos, V., Rui, L., Hill, K.M., et al. A RING-type ubiquitin ligase family member required to repress follicular helper T cells and autoimmunity. Nature 435:7041 (2005), 452–458.
144. Vollmer, T.L., Liu, R., Price, M., Rhodes, S., La Cava, A., Shi, F.-D., Differential effects of IL-21 during initiation and progression of autoimmunity against neuroantigen. J. Immunol. 174:5 (2005), 2696–2701.
145. Wan, C.-K., Oh, J., Li, P., West, E.E., Wong, E.A., Andraski, A.B., et al. The cytokines IL-21 and GM-CSF have opposing regulatory roles in the apoptosis of conventional dendritic cells. Immunity 38:3 (2013), 514–527.
146. Webb, R., Merrill, J.T., Kelly, J.A., Sestak, A., Kaufman, K.M., Langefeld, C.D., et al. A polymorphism within IL21R confers risk for systemic lupus erythematosus. Arthritis Rheum. 60:8 (2009), 2402–2407.
147. Williams, L.D., Bansal, A., Sabbaj, S., Heath, S.L., Song, W., Tang, J., et al. Interleukin-21-producing HIV-1-specific CD8 T cells are preferentially seen in elite controllers. J. Virol. 85:5 (2011), 2316–2324.
148. Xu, W., Narayanan, P., Kang, N., Clayton, S., Ohne, Y., Shi, P., et al. Human plasma cells express granzyme B. Eur. J. Immunol. 44:1 (2014), 275–284.
149. Yoshizaki, A., Tedder, T., IL-21 induces regulatory B cell differentiation and immunosuppressive effect through cognate interaction with T cells. Nihon Rinsho Men'eki Gakkai kaishi (Japanese) 38:1 (2014), 57–64.
150. Yoshizaki, A., Miyagaki, T., DiLillo, D.J., Matsushita, T., Horikawa, M., Kountikov, E.I., et al. Regulatory B cells control T-cell autoimmunity through IL-21-dependent cognate interactions. Nature 491:7423 (2012), 264–268.
151. Young, D.A., Hegen, M., Ma, H.L.M., Whitters, M.J., Albert, L.M., Lowe, L., et al. Blockade of the interleukin-21/interleukin-21 receptor pathway ameliorates disease in animal models of rheumatoid arthritis. Arthritis Rheum. 56:4 (2007), 1152–1163.
152. Yu, D., Rao, S., Tsai, L.M., Lee, S.K., He, Y., Sutcliffe, E.L., et al. The transcriptional repressor Bcl-6 directs T follicular helper cell lineage commitment. Immunity 31:3 (2009), 457–468.
153. Zeng, R., Spolski, R., Finkelstein, S.E., Oh, S., Kovanen, P.E., Hinrichs, C.S., et al. Synergy of IL-21 and IL-15 in regulating CD8+ T cell expansion and function. J. Exp. Med. 201:1 (2005), 139–148.
154. Zhou, L., Ivanov, I.I., Spolski, R., Min, R., Shenderov, K., Egawa, T., et al. IL-6 programs TH-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways. Nat. Immunol. 8:9 (2007), 967–974.
155. Zotos, D., Coquet, J.M., Zhang, Y., Light, A., D'Costa, K., Kallies, A., et al. IL-21 regulates germinal center B cell differentiation and proliferation through a B cell—intrinsic mechanism. J. Exp. Med. 207:2 (2010), 365–378.